Disparities in Prescription Drug Access: A Growing Concern for Black Canadians
A recent study published in the Canadian Medical Association Journal reveals a troubling disparity: Black Canadians are less likely than their white counterparts to be able to afford their prescription medications. The research, led by Dr. Bukola Salami of the University of Calgary, highlights the significant impact of socioeconomic inequalities on health outcomes within the Canadian healthcare system.
The Numbers Tell a Story
The study analyzed five years of data from the Canadian Community Health Survey (2015, 2016, 2018, 2019, and 2022) and found that approximately 10-15% of Black adults reported not filling prescriptions or skipping doses due to cost, compared to around 6% of white adults. Even when factoring in income and insurance coverage, this gap persisted. Currently, about 72% of Black adults have prescription drug coverage, compared to 80% of white adults.
Beyond Finances: The Role of Systemic Mistrust
Dr. Salami’s research suggests that the issue extends beyond financial constraints. A potential contributing factor is a deep-seated mistrust of the healthcare system, stemming from experiences of both direct and systemic racism. This mistrust can lead individuals to hesitate in seeking care or adhering to prescribed treatments.
Dr. Mojola Omole, President of the Association of Black Physicians of Ontario, echoes this sentiment. She notes that patients frequently express concerns about affording medication, and that this is compounded by a historical lack of quality care experienced by Black communities. “If people have to choose between their medications and feeding their family, they will choose to feed their family,” Dr. Omole stated.
The Impact of Canada’s Drug Coverage Landscape
Canada’s universal healthcare system does not currently include comprehensive prescription drug coverage. While the federal government passed a national pharmacare law in 2024, implementation is ongoing. As of March 2026, agreements have been reached to cover diabetes and contraception medications in British Columbia, Manitoba, Prince Edward Island, and Yukon. Other provinces and territories are still negotiating.
This patchwork approach to coverage exacerbates existing inequalities. The study’s findings underscore the urgent need for equitable access to medication, regardless of socioeconomic status or racial background.
Looking Ahead: Will Pharmacare Bridge the Gap?
Dr. Salami emphasizes that further research is needed to determine whether the national pharmacare program will effectively improve access to prescription drugs for Black Canadians. The success of the program will depend on its ability to address not only financial barriers but also the underlying issues of mistrust and systemic inequities.
Pro Tip
The Intersection of Access and Primary Care
Access to a consistent primary care provider is also a critical factor. Dr. Omole points out that individuals without a family doctor are more likely to rely on episodic care, making it harder to build trust and adhere to medication regimens.
Did You Know?
FAQ
Q: What is pharmacare?
A: Pharmacare is a proposed national program to provide universal access to prescription medications for all Canadians.
Q: Why are Black Canadians less likely to have drug coverage?
A: The study suggests this is due to a combination of socioeconomic factors, systemic inequities, and potential mistrust of the healthcare system.
Q: Will the new pharmacare program solve this problem?
A: It’s too early to say. Further research is needed to assess the program’s impact on access for Black Canadians.
Q: What can be done to address this issue?
A: Addressing systemic racism in healthcare, improving access to primary care, and ensuring equitable drug coverage are all crucial steps.
Want to learn more about health equity in Canada? Visit the Black Women’s Institute for Health.
Share your thoughts on this important issue in the comments below!
